Gibson Christopher sold RXRX
January 5, 2026 · Form 4 insider transaction
Gibson Christopher sold 40,000 shares of Recursion Pharmaceuticals, Inc. at $4.25 per share, a transaction worth $170.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
40,000
Price
$4.25
Total value
$170.0K
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after933,839
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.